| Overview |
| bsm-62956r-rbitc-100ul |
| Phospho-PKC epsilon (Ser729) Recombinant Antibody, RBITC Conjugated |
| WB |
| Human, Rat |
| Specifications |
| RBITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human PKC epsilon around the phosphorylation site of S729 |
| Ser729 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 5581 |
| Q02156 |
| Cytoplasm, Nucleus, Cell membrane |
| PKC alpha; PKC beta; PKC delta; PKC epsilon; PKC gamma; PKC zeta; PKC2; PKCA; PKCB; PKCD; PKCE; PKCG; PRKCA; PRKCB; PRKCD; PRKCE; PRKCG; PRKCZ. |
| Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays essential roles in the regulation of multiple cellular processes linked to cytoskeletal proteins, such as cell adhesion, motility, migration and cell cycle, functions in neuron growth and ion channel regulation, and is involved in immune response, cancer cell invasion and regulation of apoptosis. |
| Application Dilution |
| WB |
1:300-5000 |